- Joined
- Feb 20, 2021
This reminds me of something interesting. There's a family of chemotherapy drugs called multitargeted receptor tyrosine kinase inhibitors, which are designed to target specific genes expressed by some cancer cells. This class of medications is known for occasionally causing distinctive loss of pigmentation of the hair. Contrary to what people are taught in junior high biology class, hair color is really complicated. It's regulated by the complex interplay of the proteins encoded by multiple genes. One of these is c-KIT, which encodes a receptor tyrosine kinase protein called tyrosine-protein kinase KIT, or CD 117. This protein binds to another (called its ligand) called the stem cell factor, which is a cytokine that regulates cell growth. This is what makes c-KIT so attractive as a chemotherapy drug target. KIT is expressed in multiple cell types, including bone marrow progenitor cells, germ cells (the cells that become sperm or eggs), mast cells (a type of white blood cell), and melanoblasts (immature skin pigment cells). Stem cell factor is expressed in areas where the KIT-expressing cells need to go - basically, SCF is like a waypoint that helps certain types of cell to get to where they need to be.Neither deep brain stimulation or electroshock therapy are felt, so the effect is on misfiring neurons.
As for shock collars... Long term they give them PTSD for obvious reasons. Short term... I mean Lovett, the founder of ABA, beat the kids, and hence he only got results because the kids were terrified of him. I believe he also encouraged parents to smack em. So in the short term it works till the PTSD kicks in.
And it won't work at all in the short term for catatonia unless you're shocking em so hard they seize... and then you're just giving em a heart attack (which, unfortunately, has happened at these places).
In gene therapy news... we can change your hair color!
Basically, patients with the disease have crystals build up in all tissues due to a lack of an enzyme, but we only know its main function is breaking down cysteine. Turns out it also is involved somehow in melanin production.
So they took out some blood stem cells, murdered what they left behind, and edited the stem cells to include the enzyme. They figured since the immune cells go everywhere in the body, they'll make the enzyme everywhere. This meant the 5 patients had less crystals in all the usual places.
The enzyme also got to their hair and turned it from blonde to dark brown. The scientists didnt expect this and now might use it to determine easily if the gene therapy took.
Also interests me because of the delivery method. A massive issue for gene therapy is getting it to the brain and, whilst the brain does have its own immune system, it still lets in immune cells from elsewhere. This method could mean we dont need to inject right into the skull! There'd be less total enzyme activity, but some disorders we need only get like 1% working to solve the problem.
And you remove the risk of off-targetting. By culturing the gene-edited cells, you can take a single one out of the population and see, hey did we edit the right spot?
So, you have a receptor tyrosine kinase protein that binds to another protein to make cells, including pigment cells, go to the right place. Remember how these drugs work? They inhibit receptor tyrosine kinases, preventing them from binding to their ligand. One result is that the pigmented cells never make it to the hair.
What's really neat is that there are reports of "periodic" hair depigmentation, which means that the hair shows a "striped" pattern of pigmentation loss which corresponds to the dosing schedule of the chemotherapy (usually 4 weeks on, 2 weeks off). Some papers describe the depigmentation as "greying", but having seen it in person, it is really distinctive and looks like complete color loss.
Here's a photo of the "periodic" pattern, taken from the NEJM paper linked previously. I personally think it looks bad ass:

Also interesting is that there are a handful of reports of people whose previously grey hair regains its pigmentation during treatment with one of these drugs.
Last edited: